ResearcherShanghai Medical College of Fudan UniversityNo recent work listed
Lixiang Ma
Matched on ORCID iD 0000-0001-9399-155X; OpenAlex author ID A5059169344. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers
Papers 4
- IDO-1 inhibitor INCB24360 elicits distant metastasis of basal extruded cancer cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41401-022-01035-w↗
- Construction of a pancreatic cancer nerve invasion system using brain and pancreatic cancer organoids. Last author DOI 10.1177/20417314221147113↗
- Basal microvilli define the metabolic capacity and lethal phenotype of pancreatic cancer. First author DOI 10.1002/path.5588↗
- LSL-KrasG12D; LSL-Trp53R172H/+; Ink4flox/+; Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer. Co-author DOI 10.1371/journal.pone.0176844↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hexige Saiyin · 4 shared papers, 2017–2023 · strength 0.67
- Paper Construction of a pancreatic cancer nerve invasion system using brain and pancreatic cancer organoids. DOI 10.1177/20417314221147113↗
- Paper IDO-1 inhibitor INCB24360 elicits distant metastasis of basal extruded cancer cells in pancreatic ductal adenocarcinoma. DOI 10.1038/s41401-022-01035-w↗
- Paper LSL-KrasG12D; LSL-Trp53R172H/+; Ink4flox/+; Ptf1/p48-Cre mice are an applicable model for locally invasive and metastat… DOI 10.1371/journal.pone.0176844↗
- Hada Buhe · 2 shared papers, 2023 · strength 0.38
- Chenyun Song · 2 shared papers, 2023 · strength 0.38
- Xu Han · 2 shared papers, 2021–2023 · strength 0.32
- Wenhui Lou · 1 shared paper, 2021 · strength 0.14
- Jichun Gu · 1 shared paper, 2021 · strength 0.14
- Dansong Wang · 1 shared paper, 2021 · strength 0.14
- Ji Li · 1 shared paper, 2021 · strength 0.14
- Deliang Fu · 1 shared paper, 2021 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.